Showing results (2701-2710 of 6,778) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|December 23, 2017
Use of α2-Adrenergic Agonists to Improve Surgical Field Visibility in Endoscopy Sinus Surgery: A Systematic Review of Randomised Controlled TrialsMaria Angeles Quijada-Manuitt, Yolanda Escamilla, Antonio Vallano, et al.
Clinical Therapeutics|December 24, 2017
Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved BiologicsKen Ogasawara, Christopher D Breder, Dora H Lin, et al.
Clinical Therapeutics|January 1, 1986
New directions in nonoperative management of coronary artery diseaseE R Powers
Clinical Therapeutics|March 10, 2018
Diagnosis and Management of Immune Checkpoint Inhibitor-related Toxicities in Ovarian Cancer: A Series of Case VignettesCynae Johnson, Amir Anthony Jazaeri
Clinical Therapeutics|March 4, 2018
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysisEric M Maiese, Claire Ainsworth, Jean-Gabriel Le Moine, et al.
Clinical Therapeutics|March 3, 2018
Limited Sampling Strategy for Accurate Prediction of Pharmacokinetics of Saroglitazar: A 3-point Linear Regression Model Development and Successful Prediction of Human ExposureShuchi N Joshi, Nuggehally R Srinivas, Deven V Parmar
Clinical Therapeutics|March 6, 2018
Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII TreatmentLian A van Meijel, Sandra P van den Heuvel-Bens, Lisa J Zimmerman, et al.
Clinical Therapeutics|February 5, 2018
Valganciclovir Use Among Commercially and Medicaid-insured Infants With Congenital CMV Infection in the United States, 2009-2015Jessica Leung, Sheila C Dollard, Scott D Grosse, et al.
Clinical Therapeutics|February 6, 2018
Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese SubjectsXiaojie Wu, Yunfei Li, Jing Zhang, et al.
Clinical Therapeutics|February 7, 2018
Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO TrialSandra L Goss, Cheri E Klein, Ziyi Jin, et al.
Pageof 678